Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
roche
8
×
life sciences
national blog main
national top stories
biotech
clinical trials
san francisco top stories
boston blog main
boston top stories
san francisco blog main
amgen
boston
cancer
deals
fda
genentech
investing
national
new york top stories
novartis
alexion pharmaceuticals
alnylam pharmaceuticals
avapritinib
biogen
blueprint medicines
bristol-myers squibb
cancer drugs
drug pricing
eli lilly
europe top stories
gene therapy
hepatitis b
ifm therapeutics
indiana blog main
indiana top stories
medullary thyroid cancer
merck
new york blog main
non-small cell lung cancer
pralsetinib
What
drug
8
×
cancer
medicines
roche
fda
new
approval
bio
blueprint
currently
intended
medicine
oral
patients
pharmaceuticals
pricing
research
ret
roundup
team
therapy
address
advanced
advantages
announced
antiviral
approved
approves
arrival
atea
atrophy
award
bar
brings
candidate
carries
caught
causing
certain
coronavirus
Language
unset
8
×
Current search:
drug
×
unset
×
roche
×
@bgr.com
3 years ago
This groundbreaking new coronavirus cure is unlike any other drug we’ve seen so far
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone